merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>The $2,000 annual cap on patient costs for drugs taken at home will go into effect next year, while the new negotiated prices will take effect in 2026.</answer>

<question_number>2</question_number>
<answer>The Project 2025 playbook suggests that the drug price negotiation program should be repealed if there is full Republican control of Congress, implying a potential reversal or weakening of the program's impact on the number of drugs negotiated by the federal government.</answer>

<question_number>3</question_number>
<answer>Vice President Kamala Harris cast the tiebreaking vote for the legislation that delivered the drug price negotiation program, and she has focused some of her early presidential campaign on the Biden administration's drug pricing reforms, including the cap on monthly insulin costs for Medicare recipients.</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>N/A</answer>

<question_number>6</question_number>
<answer>N/A</answer>

<question_number>7</question_number>
<answer>Enbrel, with a negotiated price of $2,355, would require the most monthly refills before reaching the $2,000 annual cap.</answer>

<question_number>8</question_number>
<answer>N/A</answer>

<question_number>9</question_number>
<answer>The difference in negotiated price between Jardiance ($197) and Farxiga ($178) is $19.</answer>

<question_number>10</question_number>
<answer>N/A</answer>